Table 1

The mutation patterns and interaction with other gene alterations in 54 patients with ASXL1 mutations

UPNAge, y/sexFABKaryotypeASXL1 mutation
Other genetic mutations*
n.t. changea.a. change
73/F c.1772dupA p.Y591X FLT3-ITD 
73/F del(7q) c.1773C>G p.Y591X NRAS 
62/M i(17)(q10) c.1900_1922del p.E635RfxX15 RUNX1 
54/M t(3;21;8)(q12;q22;q22) c.1900_1922del p.E635RfxX15 c-KIT 
75/M der(2)dup(2)(q21q31) c.1900_1922del p.E635RfxX15 NPM1 
47/F c.1900_1922del p.E635RfxX15  
42/M t(16;21)(q24;q22), +8 c.1900dupA p.R634KfsX24 NRAS 
67/M NA No mitosis c.1918_1928del p.A640GfsX14  
65/F t(3;3) c.1934dupG G646WfsX12 NRAS 
10 75/M c.1934dupG G646WfsX12 CEBPA 
11 85/F c.1934dupG G646WfsX12 CEBPA 
12 66/M del(7q) c.1934dupG G646WfsX12 NPM1, RUNX1 
13 84/F c.1934dupG G646WfsX12 FLT3-TKD, RUNX1,MLL1-PTD 
14 70/M i(21) c.1934dupG G646WfsX12  
15 60/F t(1;3)(p36;p21) c.1934dupG G646WfsX12 FLT3-ITD, NRAS 
16 29/F +11p c.1934dupG G646WfsX12  
17 49/F −X c.1934dupG G646WfsX12 FLT3-TKD 
18 61/M c.1934dupG G646WfsX12 RUNX1 
19 42/F c.1934dupG G646WfsX12 FLT3-ITD, RUNX1 
20 72/M +8 c.1934dupG G646WfsX12 IDH1 
21 42/M t(8;21)(q22;q22) c.1934dupG G646WfsX12  
22 74/M −Y c.1934dupG G646WfsX12 RUNX1 
23 71/M del(12)(p12p13), −7 c.1934dupG G646WfsX12 RUNX1, PTPN11 
24 43/M t(8;21)(q22;q22) c.1934dupG G646WfsX12  
25 67/M +8 c.1934dupG G646WfsX12 RUNX1 
26 75/M c.1934dupG G646WfsX12 RUNX1, PTPN11 
27 79/M c.1934dupG G646WfsX12 RUNX1 
28 82/M +8 c.1934dupG G646WfsX12 RUNX1 
29 52/M Inadequate c.1934dupG G646WfsX12  
30 27/F t(8;21)(q22;q22) c.1934dupG G646WfsX12 c-KIT 
31 74/M del(5q) c.1934dupG G646WfsX12 PTPN11 
32 62/M c.1934dupG G646WfsX12 RUNX1 
33 84/M c.1934dupG G646WfsX12 RUNX1, FLT3-TKD 
34 76/M +8 c.1934dupG G646WfsX12  
35 55/F +8 c.1934dupG G646WfsX12  
36 57/M c.1934dupG G646WfsX12 CEBPA 
37 77/M Inadequate c.1934dupG G646WfsX12 RUNX1 
38 90/M c.1934dupG G646WfsX12 CEBPA 
39 55/M +8 c.1934dupG G646WfsX12 FLT3-ITD 
40 24/F t(8;21)(q22;q22) c.1934dupG G646WfsX12 NRAS 
41 44/M t(8;21)(q22;q22) c.1934dupG G646WfsX12  
42 69/M c.1934dupG G646WfsX12 RUNX1 
43 79/F +21 c.1934dupG G646WfsX12 PTPN11, MLL-PTD 
44 30/M t(8;21)(q22;q22) c.1934dupG G646WfsX12  
45 70/M c.2290delC p.L764YfsX8 MLL-PTD 
46 66/M c.2324delT pL775X NRAS 
47 84/M Not done c.2324T>G pL775X RUNX1 
48 24/M t(9;11;13)(p22;q23;q34) c.2387G>A p.W796X FLT3-TKD 
49 78/M del(11q23) c.2415delC p.T806PfsX12  
50 54/M c.2641dupA pR881KfsX13 PTPN11 
51 61/F add(5)(q22) c.2921_2922insTCTT p.C975LfsX8  
52 36/F t(8;21)(q22;q22) c.3002_3011delinsTAGGC p.T1001IfsX4  
53 22/M −7 c.4127dupG p.P1377SfsX3 FLT3-TKD 
54 67/M complex c.4363delA p.N1455IfsX20  
UPNAge, y/sexFABKaryotypeASXL1 mutation
Other genetic mutations*
n.t. changea.a. change
73/F c.1772dupA p.Y591X FLT3-ITD 
73/F del(7q) c.1773C>G p.Y591X NRAS 
62/M i(17)(q10) c.1900_1922del p.E635RfxX15 RUNX1 
54/M t(3;21;8)(q12;q22;q22) c.1900_1922del p.E635RfxX15 c-KIT 
75/M der(2)dup(2)(q21q31) c.1900_1922del p.E635RfxX15 NPM1 
47/F c.1900_1922del p.E635RfxX15  
42/M t(16;21)(q24;q22), +8 c.1900dupA p.R634KfsX24 NRAS 
67/M NA No mitosis c.1918_1928del p.A640GfsX14  
65/F t(3;3) c.1934dupG G646WfsX12 NRAS 
10 75/M c.1934dupG G646WfsX12 CEBPA 
11 85/F c.1934dupG G646WfsX12 CEBPA 
12 66/M del(7q) c.1934dupG G646WfsX12 NPM1, RUNX1 
13 84/F c.1934dupG G646WfsX12 FLT3-TKD, RUNX1,MLL1-PTD 
14 70/M i(21) c.1934dupG G646WfsX12  
15 60/F t(1;3)(p36;p21) c.1934dupG G646WfsX12 FLT3-ITD, NRAS 
16 29/F +11p c.1934dupG G646WfsX12  
17 49/F −X c.1934dupG G646WfsX12 FLT3-TKD 
18 61/M c.1934dupG G646WfsX12 RUNX1 
19 42/F c.1934dupG G646WfsX12 FLT3-ITD, RUNX1 
20 72/M +8 c.1934dupG G646WfsX12 IDH1 
21 42/M t(8;21)(q22;q22) c.1934dupG G646WfsX12  
22 74/M −Y c.1934dupG G646WfsX12 RUNX1 
23 71/M del(12)(p12p13), −7 c.1934dupG G646WfsX12 RUNX1, PTPN11 
24 43/M t(8;21)(q22;q22) c.1934dupG G646WfsX12  
25 67/M +8 c.1934dupG G646WfsX12 RUNX1 
26 75/M c.1934dupG G646WfsX12 RUNX1, PTPN11 
27 79/M c.1934dupG G646WfsX12 RUNX1 
28 82/M +8 c.1934dupG G646WfsX12 RUNX1 
29 52/M Inadequate c.1934dupG G646WfsX12  
30 27/F t(8;21)(q22;q22) c.1934dupG G646WfsX12 c-KIT 
31 74/M del(5q) c.1934dupG G646WfsX12 PTPN11 
32 62/M c.1934dupG G646WfsX12 RUNX1 
33 84/M c.1934dupG G646WfsX12 RUNX1, FLT3-TKD 
34 76/M +8 c.1934dupG G646WfsX12  
35 55/F +8 c.1934dupG G646WfsX12  
36 57/M c.1934dupG G646WfsX12 CEBPA 
37 77/M Inadequate c.1934dupG G646WfsX12 RUNX1 
38 90/M c.1934dupG G646WfsX12 CEBPA 
39 55/M +8 c.1934dupG G646WfsX12 FLT3-ITD 
40 24/F t(8;21)(q22;q22) c.1934dupG G646WfsX12 NRAS 
41 44/M t(8;21)(q22;q22) c.1934dupG G646WfsX12  
42 69/M c.1934dupG G646WfsX12 RUNX1 
43 79/F +21 c.1934dupG G646WfsX12 PTPN11, MLL-PTD 
44 30/M t(8;21)(q22;q22) c.1934dupG G646WfsX12  
45 70/M c.2290delC p.L764YfsX8 MLL-PTD 
46 66/M c.2324delT pL775X NRAS 
47 84/M Not done c.2324T>G pL775X RUNX1 
48 24/M t(9;11;13)(p22;q23;q34) c.2387G>A p.W796X FLT3-TKD 
49 78/M del(11q23) c.2415delC p.T806PfsX12  
50 54/M c.2641dupA pR881KfsX13 PTPN11 
51 61/F add(5)(q22) c.2921_2922insTCTT p.C975LfsX8  
52 36/F t(8;21)(q22;q22) c.3002_3011delinsTAGGC p.T1001IfsX4  
53 22/M −7 c.4127dupG p.P1377SfsX3 FLT3-TKD 
54 67/M complex c.4363delA p.N1455IfsX20  

UPN indicates unique patient number; FAB, French-American-British; n.t., nucleotide; a.a., amino acid; N, normal karyotype; ITD, internal tandem duplication; NA, not applicable; TKD, tyrosine kinase domain; and PTD, partial tandem duplication.

*

The gene alterations studied included FLT3-ITD, FLT3-TKD, and MLL-PTD, mutations of NRAS, KRAS, KIT, PTPN11, WT1, NPM1, JAK2, RUNX1, CEBPA, and IDH1.